Home    Contact    Sitemap    Search    
  Print page    
  

2012.02.02   Photocure’s partner Ipsen announces 4Q 11 Hexvix® sales in Germany and Italy  [Stock Exchange Notice]
2012.01.13   Photocure announces completion of Visonac® study enrolment  [Stock Exchange Notice]
2012.01.09   Photocure ASA - Photocure strengthens the Management Team  [Stock Exchange Notice]
2012.01.03   Photocure ASA - Cevira Study completes study enrolment on time  [Stock Exchange Notice]
2011.12.30   Photocure ASA: Photocure Announces Transfer of Marketing Authorisation for Cysview in the USA  [Stock Exchange Notice]
2011.12.06   DnB Nor Nordic Health Care Conference 2011  
2011.12.05   Photocure - repurchase program of own shares  [Press Release][Stock Exchange Notice]
2011.12.05   Photocure presenting at Nordic health care conference 2011  [Press Release][Stock Exchange Notice]
2011.11.29   Photocure appoints interim Chief Financial Officer  [Press Release][Stock Exchange Notice]
2011.11.28   Photocure nominates market maker on oslo stock exchange  [Press Release][Stock Exchange Notice]
2011.11.18   Photocure announces resignment of Chief Financial Officer  [Press Release][Stock Exchange Notice]
2011.11.07   3rd Quarter Report 2011  [Stock Exchange Notice]
2011.10.24   Invitation to a presentation of the 3rd quarter report 2011  [Stock Exchange Notice]
2011.10.14   Photocure announces the achievement of the first transition milestone of Eur 2.0 million for Hexvix®  [Press Release][Stock Exchange Notice]
2011.09.27   Photocure announces new commercial strategy for Hexvix®, the innovative product for improved detection of bladder cancer  [Stock Exchange Notice]


 
  Photocure ASA, Hoffsveien 4, NO-0275 Oslo, Norway. Telephone: +47 22 06 22 10 Fax: +47 22 06 22 18